BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 7685239)

  • 1. Decreased expression of epidermal growth factor and its receptor in the malignant transformation of trophoblasts.
    Ladines-Llave CA; Maruo T; Manalo AM; Mochizuki M
    Cancer; 1993 Jun; 71(12):4118-23. PubMed ID: 7685239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole.
    Yang X; Zhang Z; Jia C; Li J; Yin L; Jiang S
    Gynecol Oncol; 2002 Jun; 85(3):438-44. PubMed ID: 12051871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of the novel hydatidiform mole-related gene F10 with the invasiveness of trophoblastic tumor].
    Zhou J; Chen SL; Xing FQ; Pang ZJ; Li B; Zhou WQ; Fu X; Ding YQ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):171-3. PubMed ID: 15698997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical localization of inhibin-activin subunits in hydatidiform mole and invasive mole.
    Minami S; Yamoto M; Nakano R
    Obstet Gynecol; 1993 Sep; 82(3):414-8. PubMed ID: 8395038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of human chorionic gonadotropin/human luteinizing hormone receptors in human gestational trophoblastic neoplasms.
    Lei ZM; Rao CV; Ackerman DM; Day TG
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1236-41. PubMed ID: 1592864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in gene expression profiles of hydatidiform mole and choriocarcinoma as compared with trophoblast hyperplasia].
    Cui JQ; Shi YF; Zhou HJ; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):727-31. PubMed ID: 15733390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mismatch repair gene promoter methylation and expression in hydatidiform moles and the malignant transformation].
    Zhu CK; Ye DF; Xie X; Cheng XD; Chen HZ; Lu WG
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):422-6. PubMed ID: 12974087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 expression in placentas with hydropic change and hydatidiform moles.
    Cheville JC; Robinson RA; Benda JA
    Mod Pathol; 1996 Apr; 9(4):392-6. PubMed ID: 8729978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression patterns of ERVWE1/Syncytin-1 and other placentally expressed human endogenous retroviruses along the malignant transformation process of hydatidiform moles.
    Bolze PA; Patrier S; Cheynet V; Oriol G; Massardier J; Hajri T; Guillotte M; Bossus M; Sanlaville D; Golfier F; Mallet F
    Placenta; 2016 Mar; 39():116-24. PubMed ID: 26992684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.
    Persaud V; Ganjei P; Nadji M
    West Indian Med J; 1993 Dec; 42(4):142-3. PubMed ID: 7909185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma.
    Fulop V; Mok SC; Genest DR; Szigetvari I; Cseh I; Berkowitz RS
    J Reprod Med; 1998 Feb; 43(2):101-10. PubMed ID: 9513871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P63 expression in hydropic abortion and gestational trophoblastic diseases.
    Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
    Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered p16 and Bcl-2 expression reflects pathologic development in hydatidiform moles and choriocarcinoma.
    Candelier JJ; Frappart L; Yadaden T; Poaty H; Picard JY; Prévot S; Coullin P
    Pathol Oncol Res; 2013 Apr; 19(2):217-27. PubMed ID: 23065465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trophoblast subtype-specific EGFR/ERBB4 expression correlates with cell cycle progression and hyperplasia in complete hydatidiform moles.
    Fock V; Plessl K; Fuchs R; Dekan S; Milla SK; Haider S; Fiala C; Knöfler M; Pollheimer J
    Hum Reprod; 2015 Apr; 30(4):789-99. PubMed ID: 25740878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
    Hussein MR
    Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and significance of LMP2 and PPM1A in gestational trophoblastic disease].
    Zhang SS; Wan XY; Zhou CY; Lü WG; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):510-5. PubMed ID: 22041443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cyclin E in placentas with hydropic change and gestational trophoblastic diseases: implications for the malignant transformation of trophoblasts.
    Kim YT; Cho NH; Ko JH; Yang WI; Kim JW; Choi EK; Lee SH
    Cancer; 2000 Aug; 89(3):673-9. PubMed ID: 10931468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of c-myc and c-fms oncogenes in trophoblastic cells in hydatidiform mole and normal human placenta.
    Cheung AN; Srivastava G; Pittaluga S; Man TK; Ngan H; Collins RJ
    J Clin Pathol; 1993 Mar; 46(3):204-7. PubMed ID: 8463412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic identification of predictive biomarkers for malignant transformation in complete hydatidiform moles.
    Vanichtantikul A; Hodge KG; Somparn P; Saethang T; Triratanachat S; Pisitkun T; Lertkhachonsuk R
    Placenta; 2019 Feb; 77():58-64. PubMed ID: 30827356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional and posttranscriptional mechanisms in epidermal growth factor regulation of human chorionic gonadotropin (hCG) subunits and hCG receptor gene expression in human choriocarcinoma cells.
    Cao H; Lei ZM; Rao CV
    Endocrinology; 1994 Sep; 135(3):962-70. PubMed ID: 8070393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.